New weekly update with 2 purchases.
#dividend
#dividends
#dividende
#stocks
#stock
#invest
#investing
#etf
#etfs
$JNJ (+0.22%)
$PFE (-0.05%)
$ABBV (-0.37%)
$LLY (+0.25%)
$MRK (+0.44%)
Posts
96Keytruda: $29.48 billion in revenue in 2024, accounting for 46% of Merckâs total sales.
The King of Oncology is about to lose its crown jewel. What happens when your $30B baby hits the patent cliff?
Big Pharma, Bigger Problems
Merck & Co. is the pharma titan behind Keytruda, a cancer-fighting blockbuster that made up 46% of Merckâs total 2024 revenue. Thatâs $29.5B out of $64B. Wild.
Keytrudaâs patent expires in 2028.
You know what that means? Biosimilar wolves at the door.
Segments & Moat: Beyond the Big âKâ
Merckâs moat was exclusivity. Now itâs pivoting to:
Theyâre buying growth, tooâ$11B for Prometheus Biosciences in 2023.
Competitors: Biosimilar Bros Incoming
Big Dogs:
New Age:
đ Biosimilars typically take 30â40% market share in year 1 and cut prices by 25â50%. Thatâs ugly math for Merck.
Growth KPIs: From Leader to Lagger?
đ° †Financials Snapshot:
Merck isnât brokeâbut itâll feel a cold wind when Keytruda drops off.
Valuation Check:
Merck is trading like itâs already past the patent cliff. Thatâs⊠intriguing.
Catalysts & Risks:
Catalysts:
Risks:
đ Watchlist trigger: If biosimilar lawsuits or FDA delay biosimilar entry to 2029â30? Stock rerates fast.
Conviction Close: King-Maker or Cliff-Diver?
This is the Keytruda cliff trade. Period.
Youâre either betting Merck successfully reinvents itself before impact, or that the market has over-punished a company still printing billions.
đ„ My move? Iâm stalking a buy zone sub-$90 as EPS dips begin. A few successful indication wins or a timely biosimilar delay, and boom â weâre cooking.
Valuation asymmetry = opportunity.
Let me know what youâre seeing on $MRK đ
Are you buying the cliff⊠or waiting for the wreckage?
An interesting blog for the a further analysis: https://jimmysjournal.substack.com/p/merck-and-co-mrk-and-keytrudas-patent
Merck shares have been through a long dry spell. Just over a year ago, the share price stood at around 134 US dollars. The share is now only worth around 80 US dollars. Is the turnaround coming now?
Merck shares fall from 134 to 80 US dollars, turnaround?
Enlicitide significantly lowers LDL cholesterol, good tolerability.
P/E ratio of 10, dividend over 4%, share a bargain.
Merck has reached an important milestone with its drug Enlicitide Decanoate, which is currently in development, in two late-stage clinical trials. As the US pharmaceutical company announced on Monday, the drug was able to achieve its main objective - a significant reduction in LDL cholesterol - in both trials.
The orally administered drug is aimed at hyperlipidemia, a lipid metabolism disorder in which excessive amounts of fats accumulate in the blood vessels. The focus is particularly on LDL cholesterol, also known as "bad cholesterol", which is considered a risk factor for cardiovascular disease
Enlicitide was tested on patients with existing heart disease or an increased risk of heart disease. Merck speaks of a "significant" and "clinically relevant" reduction in LDL levels compared to previous standard therapies.
The research results could represent a turning point for the share price.
---
## 1. Key Insights
- **Strong Competitive Moat**: Merck holds a durable advantage through patent-protected products like Keytruda, brand equity, and a robust global R&D platform. These provide sustained pricing power and high barriers to entry.
- **Attractive Valuation**: Multiple valuation methodsâincluding DCF and relative metricsâsuggest the stock is undervalued. A DCF-based intrinsic value of ~$120 per share implies ~35% upside from current levels (~$77.72).
- **Operational Resilience**: Merck demonstrates strong operational efficiency with high gross (77%) and operating (38%) margins, consistent free cash flow generation, and prudent capital deployment.
- **Income + Growth Play**: With a 4.2% dividend yield and a history of stable payouts, the stock offers income stability. However, its Chowder Number (6.07%) is below ideal thresholds for dividend growth investors.
- **Financial Strength**: Merck maintains low leverage (Net Debt/EBITDA ~0.7x) and a strong interest coverage ratio (~16x), supporting both liquidity and capital flexibility.
- **Management Effectiveness**: High ROE (39.3%) and ROA (13.8%) indicate exceptional capital and asset utilization, driven by effective executive decisions and allocation strategies.
---
## 2. Core Evaluation Areas
### đ Valuation
- **P/E (TTM)**: 11.2x (below peer median of ~13x)
- **PEG**: 0.77 (suggesting undervaluation relative to growth)
- **P/FCF**: 11.5x
- **Intrinsic Value (DCF-based)**: ~$120
- **Margin of Safety**: ~35% from current price
### đ Growth Potential
- **Short-term**: Potential FDA approvals and pipeline expansion (e.g., MoonLake acquisition talks, new RSV therapy)
- **Long-term**: Oncology and vaccine franchises, supported by consistent R&D reinvestment (~20% of revenue)
### âïž Operational Efficiency
- **ROIC**: ~20.9% vs. **WACC**: ~6.1% â strong value creation
- **FCF Margin**: ~26%
- **CapEx/Revenue**: ~5% â capital-light relative to pharma norms
### â ïž Risk Factors
**Company-Specific**
- Patent cliff: Keytruda loses exclusivity in 2028; substantial revenue exposure
- Litigation risk: Ongoing Fosamax-related lawsuits
- Modest dividend growth rate
**Systemic/Market**
- Exposure to global trade tensions (e.g., China tariff impact of $200M in Q1 2025)
- FX sensitivity due to global footprint
- Potential biosimilar threats and regulatory pricing pressures
---
## 3. Supporting Metrics & Peer Comparison
| Metric | Merck (MRK) | Peer Median (JNJ, PFE) |
|----------------------|-------------|-------------------------|
| Dividend Yield | 4.2% | 2.5%â3.5% |
| ROE | 39.3% | ~25% |
| Net Debt/EBITDA | 0.7x | 1.5xâ2.0x |
| Interest Coverage | 16.2x | >10x |
Merck outperforms peers in profitability and balance sheet strength, offering superior downside protection and shareholder returns.
---
## 4. Risk Assessment & Categorization
| Risk Area | Risk Level | Mitigants/Notes |
|-------------------|------------|---------------------------------------------------------------|
| Patent Expiry | High | Active M&A and pipeline development to offset future gaps |
| Litigation | Medium | Ongoing but manageable based on Merckâs legal reserves |
| FX & Tariffs | Medium | Partially mitigated by diversified global revenue |
| Valuation Risk | Low | Currently trading at a discount to intrinsic value |
---
## 5. Conclusion & Recommendation
- **Intrinsic Value Estimate**: ~$120 per share
- **Current Price**: ~$77.72
- **Margin of Safety**: ~35%
- **Final Rating**: **BUY**
**Summary**: Merck represents a rare blend of quality, resilience, and undervaluation. While risks like patent expirations and litigation exist, the companyâs strong financial footing, high ROIC, consistent FCF, and long-term R&D investment make it well-suited for a conservative, long-term investor.
---
Dear people
I have dealt with $ORLY (+0.24%) dealt with
also about Tradingview
in my opinion strongly overvalued, kgv historically also very high
currently well above the 200 week linesee my chart
what is your opinion?
according to investing but fairly valued
I would sell and use the cash $NOVO B (-1.82%)
$MRK (+0.44%)
$PEP (+0.12%) and $ATCO B (-1.29%) buy more
As always, first the link to the first post, where you will also find the links to all the other parts https://getqu.in/cbIOkg/
Today there are a few more details on the indicators from part 3 https://getqu.in/9XGYtO/
As described in part 3, I start my analysis with the SMA 200 / 50 / 5 daysto get an overview of the trend.
Example $UBER (-0.19%)
For me, an important setting for the SMA is that I always use the SMA regardless of my chart setting always on a daily basis. daily basis. This means that even if I have set the chart to weekly or 4h, it always shows me the SMA on a daily basis.
Example $UBER (-0.19%) 1h hour chart - but the SMA are still on a daily basis, not like the default setting, which always refers to the chart - then the SMAs would be calculated on a 200 / 50 / 5 hour basis!
Next, I'll get the VRVP to see the volumes. I have set the chart to the range since Uber has been in an overarching sideways phase.
I can see the price area with the highest volume and the distribution where 68% of the volume has taken place.
My VRVP settings are as follows, I adjust the line size depending on the visible range - the larger the range, the larger the number of lines.
So, I now have a good overview of the trend after a few minutes.
Now it's time to continue with the VWAP. My anchored VWAP I place it in a prominent position for me. In this case the last low before the start of the sideways phase. This is how I see the "DNA" of Uber - How does Uber behave in the statistical areas of the volume-weighted average price.
For my short-term trades, I zoom into the close range, but the anchored VWAP remains. I only switch to the 1 hour chart and the last few months.
The white circles then show potential entries and exits for me. The orange circles at the bottom show the earnings, there's always a lot of movementđ
Of course, I also look in detail at the price action, i.e. the candles per time unit.
In principle, this describes my main procedure for determining the buy/sell point.
That's it đ€·ââïž has been working for me for a long time with the outcome as described in part 2 https://getqu.in/TVNdpR/
Because of the overview, I have hidden the VRVP in the VWAP views, but I always leave it on for my analysis.
Example anchored VWAP with VRVP and SMA5 for the short-term trend
Example anchored VWAP with VRVP and VWAP on a weekly basisI can see where the VWAP of the current week has moved. It's also nice to see how and where the big volumes of the week have positioned themselves đ
So, that's a bit more detail on my setup. As you can see, with a little practice and routing, you can analyze a stock in a short time. For me, such an analysis usually takes no longer than 10 minutes and I know whether a trade makes sense for me and where to place my buy and sell orders.
PS: I have found a clever script on TradingView for some of my stock screener filters. You can always display some criteria live - in the chart at the bottom right
You can find it under the indicators: Ticker Dashboard For Better Stock Selection
$ADYEN (+0.94%)
$MMK (-0.4%)
$MRK (+0.44%)
$KTN (-1.14%)
$BRBY (-0.11%)
$OMV (+0.8%)
$VER (-0.19%)
$BG (-0.28%)
$VOE (-0.18%)
$ZAL (-1.51%)
$VRTX (+0.99%)
$RDC (-0.51%)
+ 6
As always, first the link to the first post, where you will also find the links to all the other parts https://getqu.in/cbIOkg/
Thanks to the bad weather, the next part will be published before the weekend! đšđš Next week I'll be traveling for work from Monday to Wednesday - so long posts will be difficult. But maybe I'll be able to pick up some exciting insights from SAP & Amazon. đ
I'm pretty busy, but if anyone happens to be at SAPPHIRE in Madrid... đ»
Today I'll give you an insight into my trading setupbut first I'll briefly talk about the outcome bias. This is an important topic that can become a trap, especially at the beginning of trading.
Outcome bias
Outcome bias is the misconception that the quality of a trade is determined by the result. Anyone who enters into a trade on the straight and narrow and then makes a profit often thinks they have got the hang of it. I like to compare it to a casino: I bet on red, win and consider myself "strategic" đ€Șđ
When trading, it is important to success or the strategy by the repeatability by repeatability. By clear rules. A strategic trade can lead to a loss. An intuitive decision can lead to a profit. Anyone who makes the latter the yardstick for their trading is undermining long-term success.
đ Remember: In trading, it is not those with courage and luck who are rewarded in the long term, but the systematic ones!
This leads us straight to the first details of my setup.
What are my premises?
I have tried a few things, but for my trading behavior shares have proved to be the most sustainable with the best profit/loss ratio.
Over the years I have tried all kinds of indicators and oscillators. From RSI, MACD, Fibonacci, all possible trend lines, so that the actual chart progression was barely visible đ€Ș
Trading not just for the sake of trading. Quality before quantity, if it doesn't fit or if time is tight, then I don't trade for a week or two.
Now that you know that my focus is only on equities, I'll move on to stock selection. In my opinion, this is just as important as chart analysis and deriving entry and exit points.
What are my filter criteria for screening?
The daily range is the range between the daily high and the daily low, a large range facilitates short-term trading, e.g. intraday or only a few days
These two filters ADV and $VOL ensure the liquidity to get out of the trade at any time.
I am not a fan of penny stocks and very small market capitalization
I also like to trade around earnings, there's often a lot of movement.
In general, I like stocks that are moving in a sideways trend, or prices that are at the VWAP or at one of the outer edges of the deviation bands.
What are my indicators for chart analysis?
Attention ONLY for trend determination - is not used for entry/exit points!
Conclusion: I only use SMA and volume, no more, but also no less.
PS: A short "deepdive" on the indicators, the exact settings, etc. will follow in a separate postđ https://getqu.in/Ka18zh/
In general, I always start my analysis on the stock's home exchange. First a quick look at the last 10 years in the weekly chart, then I continue with the daily chart looking at the last 2-3 years and then the close range of the last months or even just days, depending on how the time horizon of my trade is set up. In the close range, I also like the 4h, 1h or 15min chart. The whole thing is overlaid with the 3 SMAs 200 / 50 and 5 days for the short-term trend.
Once I have a good overview of the trend, I move on to the 2nd layout with VRVP and VWAP or aVWAP. I am always happy when significant volumes of the VRVP coincide with the VWAP or the bandwidths 1 and 2 of the anchored VWAP. According to my statistics, the success rate is highest here. Depending on which exchange I want to trade on, I then also set the chart to this exchange.
I could write endlessly about volume in connection with the VWAP, but that would go beyond the scope of this article. Volume highs, volume lows, POC, volume area, deviation bands 1 and 2, etc...
To see how I use these indicators, you are welcome to read my posts on $NOVO B (-1.82%) or also $UBER (-0.19%) to see them. Or also my short 5min analysis for $MRK (+0.44%) which I recently created for my compatriot @7Trader recently. You can find them all in the feed of my profile from the recent past.
Should I go into more detail on charts & inferences in my future trading posts? Let me know in the comments!
So, that's it again for today - have a nice week!
Click here for part 4
TL;DR like to roast my deposit, appreciate all opinions!
I always find the many posts here and reading various biographies very interesting, so I've wanted to say a few words for a while now.
Tried early, but started late
I am now 32 and unfortunately started investing seriously far too late, studied far too long, and with the larger salaries finally built up as much as possible and tried to catch up as quickly as possible. "Unfortunately" means for the most part the past calendar year, which is why I put a large part of my money into shares at already high prices and then had very little cash left in the crash to add to it. Fully invested, in other words. During the crash, I mainly reallocated and continued to fully invest what was left over from my monthly salaries.
Yet back in 2011, at the age of 18, I had a share called Facebook and a Starbucks share in my portfolio without much of a clue. I just wanted to know what my mother was actually doing with her shares and how it worked, and with FB and Starbucks I simply chose two companies that "everyone" uses/needs anyway. The idea wasn't that stupid, it worked, and after a short time I was happy about the small profit in absolute terms, sold the shares at DiBa despite the high fees at the time and simply forgot about shares for years - wealth accumulation, a word that wasn't in my vocabulary, the money I had was simply turned upside down as a young adult. Well, young me, just leave the shares lying around or, even better, take a closer look at them and carry on, it "might" have been worth it...
Of priorities and wrong horses
The years went by without any shares, but with lots of fast food and partying, but at least things have changed. At some point, I started to think about the future and wealth accumulation, first taking an interest in interest rates, and then the logical next step was dividends and shares. Unfortunately, it started rather haphazardly. As a student, I started investing small amounts, and of course betting on the wrong horses. Speculative lithium shares were particularly bad in this phase, unfortunately these were large sums even by my standards, from my grandfather's estate. That was bad. However, crypto was a very good horse, more precisely $BTC (+2.32%) and $ETH (+1.95%) which (as a computer scientist) I became interested in early on and exited several times with high profits, also thanks to domestic mining. It's just stupid that back then, in the last decade, I would never have imagined how cryptos would develop. If I had, I would have simply left it all, or at least part of it. You learn and you're always smarter afterwards anyway.
Fully invested - excessive, unhealthy, or simply good housekeeping?
So now I'm 32 - and proud of a portfolio that I think I've built up to a good size in a relatively short time. Which has given me other ideas for some time now. I'm still a long way from reaching my goal, but I have to get back on the "invest 100%" path, which has been completely contrary to my past for a long time now, and strangely enough, I'm finding it difficult to do so - something to reflect on. There are too many (supposed?) opportunities every day. So I simply could not $UNH (-0.07%) after a long period of observation yesterday and of course the savings plans had to run today too. I think I've always been good at budgeting, or let's put it this way, at least good at getting by with the money available to me in a perfectly timed way, but "indulging", not just in company shares, may become a little more prominent again. I don't go without noticeably in everyday life, I need very little, which I don't think is a bad quality to begin with. But I have changed a lot in the area of "consumption" compared to the past. I think it would be good to find a healthy balance. In my opinion, just as you don't just live to work, but work to live, the same applies to saving/investing. I actually read a post here on gq today that described exactly that and I could relate to it very well. So, reflection and taking your foot off the gas is allowed - no, it's a must! I am familiar with frugalists, but I never wanted to be one. I'd be interested to know if anyone else here feels the same way, or did?
Wrong decisions, mistakes... and (hopefully) the right conclusions
Back to the topic! (Not only) on the way to today's portfolio I have made many wrong decisions, as already mentioned, so I thought that a well-kept portfolio roast could do me some good. Other, new opinions and assessments can't be bad!
In particular, in the past I have often missed the opportunity to simply let profits run their course and instead dragged losses around with me for too long (which brings us back to lithium). A thought that I recently had again when I was thinking about when it would make sense to $HIMS (-0.07%) possibly realize, as an example. $PLTR (+0.61%) and $NVDA (-0.3%) are two examples that, like so many others, I naturally had on my radar, but they always seemed too expensive, the setback never came and I really missed the big rallies as a result. At the same time, I also get caught out by FOMO from time to time. So in both good and bad phases, I try not to just see red or green, fear or hope, but simply to evaluate what actually makes sense "from now on". Sometimes you realize a loss in order to try your luck elsewhere, sometimes you should let profits run, sometimes take them, sometimes endure the dip, sometimes be courageous and sometimes defensive. Easier said than done. I find it very nice and helpful to exchange ideas on this platform and how open and "yet" respectful it generally is. Of course, I will most likely never reach some portfolio sizes, but you can always learn something about how some people manage their portfolios, regardless of the absolute figures. You will always make mistakes, but at least you should deal with them correctly and draw the best possible conclusions.
Portfolio restructuring, planned investments / savings plans
And today? After some evaluation, research, regrouping and restructuring, I now have fewer, but still quite a few positions in different sectors, most of which are already of a decent and roughly balanced size. My medium-term plan is now to build up all positions to a certain target size. This is why I am currently running savings plans:
ETF/ETC:
Partly with small weekly amounts, until enough cash is available to fill the target position evenly. With $AVGO (-0.05%) for example, there is not much left. Also $BRK.B (-0.18%) / $APH (+0.37%) and others are already approaching the target. In some cases with somewhat larger sums for still small but prioritized positions, until opportunities and/or resources for individual purchases arise, such as the $ALV (-0.34%) and $RSG (-0.14%) should be mentioned here, as well as $DGE (-1.35%) as a turnaround candidate.
Once the aforementioned positions are full, I would like to turn my attention to the more defensive candidates that are already in the portfolio but which I am currently prioritizing - $MCD (+0%) / $KO (+0.34%) / $CCEP (+0.37%) / $ULVR (+0%) and others - and finally increase the ETF and gold share in the long term.
$VKTX (-0.07%) is a bit of a gamble, as I have actually said goodbye to pharma - $ABBV (-0.37%) / $NOVO B (-1.82%) / $LLY (+0.25%) and $MRK (+0.44%) were still part of the inventory until recently. Instead, I decided to go with $DXCM (+0.26%) / $ISRG (-0.5%) / $DHR (-1.35%) on medical technology.
$BTC (+2.32%) remains a fixed value in the portfolio, while I $ETH (+1.95%) (incorrectly entered due to staking - around 0.4 shares or âŹ1000) and $XRP (+2.76%) would/will sell at corresponding prices.
I still lack around âŹ15,000 in individual stocks at current prices to bring all positions to the current desired/dream target. This will take some time, but is foreseeable. And then I would be really quite proud and happy "as things stand now"! In any case, I now feel very comfortable on the path I have chosen and, as I said, I have to stop myself from forgetting that not all money has to be invested all the time.
Savings rate
To put this into figures, I have averaged a savings rate of around âŹ1500 over the last 24 months, with an average of âŹ100 a month in dividends. 1400⏠investment, that's about 82% of my monthly budget after deducting all "unavoidable" fixed costs including fuel and household, but not including consumption such as clothes, going out or vacations. Exaggerated, I can't say otherwise myself. But at least I have a good reason to step on the gas and get the compound interest going.
So what is all this for?
In the long term, my girlfriend and I dream of owning a property somewhere on the Croatian Adriatic, her homeland, and where I was able to spend many wonderful weeks with my parents every year as a child. A beautiful region that I consider an important part of my life, with many great moments and memories that may become even more. I hope to get closer to this goal "quickly" with the depot. The language is already halfway there! :)
In the long term, this would probably involve a little reallocation into value dividend payers, which should help with repayment. However, I would also like to lay the foundations for later distributions today, without neglecting growth. There is probably no perfect mix for this, but you are welcome to rate mine.
So, unfortunately I was once again unable to be brief. Thank you for reading, whoever has made it this far, and for your comments! I'm very excited and wish you all a great weekend.
Merck backtracks on annual forecast + Deutsche Telekom increases profits significantly + Siemens grows strongly + Mediamarkt parent Ceconomy improves profitability + RWE records losses as expected
Merck $MRK (+0.44%)rows back with annual forecast
Deutsche Telekom $DTE (+0%)increases profit significantly
Siemens $SIE (-0.02%)grows strongly
Mediamarkt parent company Ceconomy $CEC (+0.25%)improves profitability
RWE $RWE (+0.67%)records losses as expected
Thursday: Stock market dates, economic data, quarterly figures
08:00 DE: Wholesale prices April
08:00 UK: GDP (1st release) | GDP March | Trade Balance March | Industrial Production March
08:45 FR: Consumer prices April
09:00 FR: ECB Director Cipollone, speech at French payments forum
11:00 EU: GDP (2nd release) 1Q Eurozone FORECAST: +0.4% yoy/+1.2% yoy 1st release: +0.4% yoy/+1.2% yoy 4th quarter: +0.2% yoy/+1.2% yoy
11:00 EU: Industrial Production March Eurozone FORECAST: +1.1% yoy/+2.1% yoy Previous: +1.1% yoy/+1.2% yoy
14:30 US: Initial jobless claims (week) PROGNOSE: 226,000 previous: 228,000 | April producer prices PROGNOSE: +0.3% yoy previous: -0.4% yoy | Philadelphia Fed Index May PROGNOSE: -10.5 previous: -26.4
14:30 US: Retail Sales April PROGNOSE: +0.1% yoy previous: +1.4% yoy Retail Sales ex Motor Vehicles PROGNOSE: +0.3% yoy previous: +0.5% yoy 14:30 US: Empire State Manufacturing Index May PROGNOSE: -9.0 previous: -8.1
15:15 US: Industrial Production and Capacity Utilization April Industrial Production PROGNOSE: +0.1% yoy previous: -0.3% yoy Capacity utilization PROGNOSE: 77.8% previous: 77.8%
16:00 US: Inventories March PROGNOSE: +0.2% yoy previous: +0.2% yoy
Link to the first post https://getqu.in/cbIOkg/
I will also link all parts in the first post and pin the first post in my profile.
This part of the post is about the following 2 topics
To Buy&Hold I don't need to explain much more here đ It's a well-known and proven method, particularly suitable for more passive investors or those who don't want to deal with the stock market on an ongoing basis. Start with a savings plan - "time in the market" pays off!
When trading the situation is somewhat different. Active trading is required here. "Timing the market" is the motto. With the appropriate knowledge, a careful approach, good risk management and, above all, discipline, it is far more than just "gambling" or "gambling".
When I analyze my losing trades, the cause is almost always a lack of discipline, such as impatience or poor risk management. Sounds simple, but it's not... "The spirit was willing, the flesh was weak" đ€Șđ€·ââïž
Conclusion:
The last two points in the conclusion are a good transition to the topic "Prerequisites for trading". In my view, in addition to the points already mentioned, the following aspects are essential in order to be sustainably profitable:
Money management:
On the subject of money management, I would like to refer you to one of my older posts. It is essentially about determining the capital investment and the position size based on the maximum acceptable loss.
A proven guideline in trading is: Never risk more than 0.5% to max. 1% of your available capital per trade. You can find details on this in the following post https://getqu.in/tzhXqc/
Trading Tool:
Since trading is all about "timing the market", there is no getting around a trading tool. There are several tools on the market, and almost all of them offer a free version to get you started. The free versions are usually not sufficient for professional trading, as important indicators and data are missing. However, they are perfectly adequate for starting out and testing a little.
Tip: Use the free trial months of the subscription models to decide for yourself whether and which paid subscriptions are of interest to you.
I use TradingView https://www.tradingview.com and I'm really happy with it. In addition to the chart tool, there are lots of functions such as share screeners, market information, watchlists, price alerts, calendars for events such as earnings and dividends and a news feed. There is also a community, but I haven't used it yet.
Tip for beginners: TradingView also offers a demo account (paper trading), where you can safely start trading and test your strategies without using real money. Paper Trading â main functionality â TradingView
If you are interested in TradingView, I can offer you a referral link (just ask for it in the comments - I don't want to actively post the link here). Then we both get 15$ each credited to the fees. PS: I am not a Finfluencer and have nothing else to do with TradingView. It is not a source of income nor the goal of these posts - it would just be the usual friend-referral.
Knowledge of chart analysis:
Well, as written above, "a fool with a tool is still a fool". Of course, you can't do it without learning and dealing with the subject. The trading tools are all very helpful, but without understanding what you are doing with them and how to use the charts, indicators or oscillators, it won't work. Fortunately, today there are lots of tutorials on YouTube, communities etc. where you can acquire knowledge free of charge.
There will be more on chart analysis in the last part of the articles when it comes to my trading setup.
Discipline:
This last point is the most important; in combination with the 3 previous points, discipline is the key to success. Even long-time traders are subject to FOMO with accompanying ill-considered or not properly analyzed trades. This often ends the way it must... "Know yourself and your trading behavior!"
Please note, this article only reflects my experience. There are many different approaches to trading - there is no right or wrong. In the end, everyone has to find a setup that suits them.
Actually, I wanted to cover the first three points today, but as this post is already quite long, I'd rather end it in the spirit of TL:TR and will cover the points "Time spent" and "Trade frequency" in the next post. Possibly also "Profit and loss trades YTD 2025", which would fit in with the trade frequency / number of trades.
PS: as I'm traveling for work for the rest of the week, there won't be any more parts until next week.
Click here for part 2
In the feed of the linked shares you will find posts from the last few days/weeks from me $UBER (-0.19%)
$ADYEN (+0.94%)
$MMK (-0.4%)
$VRTX (+0.99%)
$RDC (-0.51%)
$KTN (-1.14%)
$NOVO B (-1.82%)
$MRK (+0.44%)
Top creators this week